Literature DB >> 646416

Occurrence of circulating immune complexes in beta-thalassaemia major.

P Casali, P Borzini, D Vergani, G Mieli-Vergani, G Masera, C Zanussi.   

Abstract

The presence of circulating soluble immune complexes and the level of complement were investigated in sera from 21 patients with beta-thalassaemia major, including both splenectomised and nonsplenectomised patients. A high level of immune complexes was found in half of these cases. Reduced complement levels were seen less frequently. There was no correlation between the presence of circulating immune complexes, decreased complement levels, and thpresence or absence of the spleen. The level of immune complexes increased with the age ofthe individual, i.e. with the duration of the disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 646416      PMCID: PMC1545323          DOI: 10.1136/adc.53.2.141

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  7 in total

1.  The management of thalassemia major.

Authors:  H A Pearson; R T O'Brien
Journal:  Semin Hematol       Date:  1975-07       Impact factor: 3.851

2.  Rabbit C1q: purification, functional and structural studies.

Authors:  J E Volanakis; R M Stroud
Journal:  J Immunol Methods       Date:  1972-11       Impact factor: 2.303

3.  Streptococcal infection leading to cardiac and renal involvement in thalassaemia.

Authors:  P Wasi
Journal:  Lancet       Date:  1971-05-08       Impact factor: 79.321

4.  Effect of chemical and enzymatic radioiodination on in vitro human Clq activities.

Authors:  C Heusser; M Boesman; J H Nordin; H Isliker
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

5.  The Raji cell radioimmune assay for detecting immune complexes in human sera.

Authors:  A N Theofilopoulos; C B Wilson; F J Dixon
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

6.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

7.  Role of chronic hepatitis in development of thalassaemic liver disease.

Authors:  G Masera; G Jean; G Gazzola; M Novakova
Journal:  Arch Dis Child       Date:  1976-09       Impact factor: 3.791

  7 in total
  1 in total

1.  Lymphocyte changes in beta-thalassaemia major.

Authors:  S Musumeci; G Schiliro; M A Romeo; A Sciotto; A Rosalba; G Pizzarelli
Journal:  Arch Dis Child       Date:  1979-12       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.